Abstract
Inflammation has been very evident in infectious diseases, but in recent times research has increasingly shown that a range of non-infectious diseases may present with inflammatory conditions. This fact becomes important as new anti-inflammatory drugs emerge with different targets for treatment of diseases. Virtual screening (VS) involves applying computational methods to discover new ligands for biological structures from the formation of large libraries composed of a large number of compounds. This review aims to report several studies employing a variety of VS: ligand-based and structure-based VS are being used more frequently in combination to decrease the probability of choosing false positive candidates. There are also studies that use only one approach. Docking is widely employed as structure-based VS methodology, however pharmacophore models based on the structure are becoming more prevalent. Molecular dynamics simulations, despite their computational cost, are still utilized to validate docking scores and analyze the stability of the complex ligand-structure. It is important to note that several studies employed several drug-like rules to screen structures, as well, decoys and PAINS to validate the models. Natural product databases, despite the lower number of the compounds compared to other databases that are available, are commonly referred to as a source of drug-like molecules. There is a literal explosion of software being released for a variety of purposes and several of them are free tools and/or web tools. Overall, VS studies are nowadays a normal part of medicinal chemistry to determine novel potential inhibitors for targets of inflammatory diseases.
Keywords: Virtual Screening, structure-based, ligand-based, inflammatory diseases, targets, (Q)SAR.
Current Pharmaceutical Design
Title:Virtual Screening Studies for Discovery of Novel Inhibitors of Inflammatory Process Targets
Volume: 24 Issue: 14
Author(s): Marcus Tullius Scotti*, Mateus Feitosa Alves, Chonny Alexander Herrera-Acevedo and Luciana Scotti
Affiliation:
- Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, Joao Pessoa,Brazil
Keywords: Virtual Screening, structure-based, ligand-based, inflammatory diseases, targets, (Q)SAR.
Abstract: Inflammation has been very evident in infectious diseases, but in recent times research has increasingly shown that a range of non-infectious diseases may present with inflammatory conditions. This fact becomes important as new anti-inflammatory drugs emerge with different targets for treatment of diseases. Virtual screening (VS) involves applying computational methods to discover new ligands for biological structures from the formation of large libraries composed of a large number of compounds. This review aims to report several studies employing a variety of VS: ligand-based and structure-based VS are being used more frequently in combination to decrease the probability of choosing false positive candidates. There are also studies that use only one approach. Docking is widely employed as structure-based VS methodology, however pharmacophore models based on the structure are becoming more prevalent. Molecular dynamics simulations, despite their computational cost, are still utilized to validate docking scores and analyze the stability of the complex ligand-structure. It is important to note that several studies employed several drug-like rules to screen structures, as well, decoys and PAINS to validate the models. Natural product databases, despite the lower number of the compounds compared to other databases that are available, are commonly referred to as a source of drug-like molecules. There is a literal explosion of software being released for a variety of purposes and several of them are free tools and/or web tools. Overall, VS studies are nowadays a normal part of medicinal chemistry to determine novel potential inhibitors for targets of inflammatory diseases.
Export Options
About this article
Cite this article as:
Scotti Tullius Marcus *, Alves Feitosa Mateus, Herrera-Acevedo Alexander Chonny and Scotti Luciana , Virtual Screening Studies for Discovery of Novel Inhibitors of Inflammatory Process Targets, Current Pharmaceutical Design 2018; 24 (14) . https://dx.doi.org/10.2174/1381612824666180403122410
DOI https://dx.doi.org/10.2174/1381612824666180403122410 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review of Wavelet Denoising in MRI and Ultrasound Brain Imaging
Current Medical Imaging Aptamer Based Diagnosis: A Cost-Effective and Suitable Point of Care Testing Method Against SARS Coronavirus-2 (SARs-CoV-2) and Other Rapidly Spreading Diseases
Current Biotechnology Synthesis and Preliminary COX-2 Expression Inhibitory Activities of Andrographolide Derivatives
Letters in Drug Design & Discovery Architecture and Conservation of the Bacterial DNA Replication Machinery, an Underexploited Drug Target
Current Drug Targets Epigenetic-related Effects of COVID-19 on Human Cells
Infectious Disorders - Drug Targets Recent Patents on Development of Nucleic Acid-based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections
Recent Patents on Anti-Infective Drug Discovery Predicting COVID-19 Severity Integrating RNA-Seq Data Using Machine Learning Techniques
Current Bioinformatics Recent Advances in the Design and Synthesis of SH2 Inhibitorsof Src, Grb2 and ZAP-70.
Current Medicinal Chemistry COVID-19 and Coinfections: A Serious Health Threat Requires Combination of Diagnosis and Therapy
Infectious Disorders - Drug Targets Thalidomide in Multiple Myeloma
Current Pharmaceutical Biotechnology A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors
Current Topics in Medicinal Chemistry Isolation and Characterization of a Trypsin-Chymotrypsin Inhibitor from the Seeds of Green Lentil (Lens culinaris)
Protein & Peptide Letters New Insights in Congenital Diaphragmatic Hernia
Current Respiratory Medicine Reviews Optimal Oxygen Therapy in the Critically Ill Patient with Respiratory Failure
Current Respiratory Medicine Reviews Natural Naphthoquinones with Great Importance in Medicinal Chemistry
Current Organic Synthesis Repurposing Ruxolitinib in Combating COVID-19: A Mini-review
New Emirates Medical Journal Catalytic Applications of Saccharin and its Derivatives in Organic Synthesis
Current Organic Chemistry Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites
Letters in Drug Design & Discovery The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies
Current Respiratory Medicine Reviews Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets